About 490mg Ledihep Ledipasvir Sofosbuvir Tablets
| Strength |
90mg/400mg |
| Packaging Size |
28 Tablets |
| Form |
Tablet |
| Brand |
Ledihep |
| Manufacturer |
Zydus Heptiza |
| Packaging Type |
Box |
| Treatment |
To Treat Chronic (Long-Lasting) Hepatitis C |
This medication is a combination of ledipasvir and sofosbuvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
Comprehensive Antiviral SolutionLedihep Tablets offer a fixed-dose combination of Ledipasvir and Sofosbuvir, specifically indicated for the treatment of chronic Hepatitis C in adults. This medication effectively targets multiple virus genotypes, making it a reliable solution in hepatitis management. Regular intake, as recommended by a healthcare professional, helps suppress viral activity and supports long-term recovery.
Key Usage and Administration GuidelinesFor best results, Ledihep should be administered orally with water, once daily, strictly following your physician's prescription. Consistency in timing and dosage is vital for maximizing antiviral efficacy. Do not adjust dosage or discontinue use without consulting your doctor to avoid compromising treatment outcomes.
Safety, Storage, and Shelf LifeLedihep must be stored below 30C and shielded from moisture and light to preserve its efficacy throughout its 24-month shelf life. Proper storage and adherence to expiration dates are critical for maintaining drug potency. If you have allergies or known hypersensitivity to any ingredients, inform your healthcare provider before use.
FAQ's of 490mg Ledihep Ledipasvir Sofosbuvir Tablets:
Q: How should Ledihep Tablets be taken for optimal results?
A: Ledihep Tablets should be swallowed whole with water, once daily, at the same time each day, as prescribed by your physician. Avoid missing doses and do not stop treatment abruptly.
Q: What is Ledihep indicated for, and who can benefit from it?
A: Ledihep is indicated for the treatment of chronic Hepatitis C infection in adults, specifically those with genotypes 1, 4, 5, or 6. Patients who require an effective direct-acting antiviral therapy benefit most from this medication.
Q: When does a patient need to discontinue Ledihep treatment?
A: Treatment should be discontinued if the patient experiences a severe allergic reaction or hypersensitivity to any of the tablet's components. Contact your healthcare provider immediately if you notice symptoms such as swelling, rash, or difficulty breathing.
Q: Where is Ledihep available and how is it packaged?
A: Ledihep is sold in India and comes in a box containing a blister pack of 28 film-coated tablets, each marked with 'L18.' You can obtain it at authorized pharmacies with a valid prescription.
Q: What are the potential side effects of Ledihep?
A: Common side effects include fatigue, headache, nausea, and insomnia. Most side effects are mild, but if they persist or worsen, consult your doctor promptly.
Q: What process should I follow for storage and expiry?
A: Store the tablets below 30C, away from moisture and light. Always check the expiry date on the box and do not use the tablets beyond their 24-month shelf life from the manufacturing date.